AC
ZBH icon

AlphaCore Capital’s Zimmer Biomet ZBH Stock Holding History

AlphaCore Capital’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.01M Buy
11,159
+2,344
+27% +$215K 0.02% 386
2025
Q4 		$793K Buy
+8,815
New +$836K 0.02% 475

Other funds holding ZBH

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCore Capital's ZBH Position: Q1 2026 in Review

AlphaCore Capital increased its Zimmer Biomet (ZBH) stake by 27% in Q1 2026, buying an estimated $215K and bringing the position to 11,159 shares worth $1.01M. The position accounts for 0.02% of the portfolio, ranked #386.

AlphaCore Capital first reported a position in ZBH in Q4 2025 and has held it in 2 quarters since. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • AlphaCore Capital held 11,159 shares of Zimmer Biomet worth $1.01M as of Q1 2026.
  • AlphaCore Capital bought 2,344 Zimmer Biomet shares in Q1 2026, an estimated $215K.
  • Zimmer Biomet made up 0.02% of AlphaCore Capital's portfolio in Q1 2026, its #386 holding.
  • AlphaCore Capital first reported a position in Zimmer Biomet in Q4 2025 and has held it in 2 quarters since.
  • 912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.